It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.

By William Baloyi When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in ...

South Africa has made history by becoming the first African nation to register Lenacapavir, a revolutionary long-acting ...

The timing of the renewed support is pivotal. South Africa is preparing to roll out Lenacapavir, a groundbreaking long-acting ...

Through a US$ 29 million grant, South Africa will receive enough medicine to provide HIV prevention to 450 000 people at high ...

South Africa has become the first African country to register lenacapavir, a groundbreaking six-monthly HIV prevention ...

South Africa has become the first African country, and our medicines regulator the third worldwide, to register the ...

South Africa has become the first African country — and our medicines regulator the third worldwide — to register the ...

In response, the South African National Treasury allocated R750 million in emergency funding to prevent service interruptions ...

The initial supply in South Africa is set to begin in April 2026, funded by a $29.2 million Global Fund grant with an additional $5 million allocated by the Networking HIV and AIDS Community of ...

Lenacapavir is a revolutionary long-acting injectable drug that offers six months of protection with just two annual ...

The U.S. President’s Emergency Plan for AIDS Relief, or PEPFAR, has been credited with saving more than 25 million lives over two decades of people with HIV, the vast majority in Africa. South Africa ...